CURRENT ISSUES OF USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: POTENTIALS FOR APPLICATION OF ACECLOFENAC
- Authors: Zhuravleva M.V.1, Zhuravleva MV1
-
Affiliations:
- Issue: No 9 (2011)
- Pages: 33-38
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278881
- ID: 278881
Cite item
Full Text
Abstract
The article discusses possible advantages of different non-steroidal anti-inflammatory drugs (NSAIDs) in terms of the effectiveness of therapy and reduction of side effects. According detailed examination and numerous clinical trials, aceclofenac (Aertal) can be considered as candidate for the role of the reference preparation among the traditional NSAIDs. Widespread use of NSAIDs requires a correct assessment of risk of unwanted side effects, administration of drugs with proven efficacy and safety, and comprehensive assessment of drug interactions. All of these factors are the basis of rational pharmacotherapy with NSAIDs.
References
- Игнатов Ю.Д., Кукес В.Г., Мазуров В.И. Клиническая фармакология нестероидных противововспалительных средств. М., 2010.
- Насонов Е.Л. Перспективы применения нового нестероидного противовоспалительного препарата нимесулид // Клин. фармакол. терапия 1999. № 8 (1). C. 65-9.
- Насонов Е.Л. Специфические ингибиторы циклооксигеназы 2 и воспаления: перспективы применения препарата целебрекс // Российская ревматология 1999. № 4. C. 2-13.
- Каратеев А.Е., Яхно Н.Н., Лазебник Л.Б. и соавт. Применение нестероидных противовоспалительных препаратов. М.,2009.
- Champion GD, Feng PH, Azuma T, et al. NSAID-induced gastrointestinal damage. Drugs 1997;53:6-19.
- Laurence DR, Bennett PN. Clinical Pharmacology. 7th ed. Churcill Livingstone, 1992.
- Insel PA. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Goodman & Gilman's. The pharmacological basis of therapeutics. 9th ed. McGraw-Hill, 1996:617-57.
- Loeb DS, Ahlquist DA, Talley NJ. Management of gastroduo-denopathy associated with use of nonsteroidal anti-inflammatory drugs. Mayo Clin Proc 1992;67:354-64.
- Espinosa L, Lipani J, Poland M, et al. Perforations, ulcers and bleeds in a large, randomized, multicenter trial of namubetone compared with diclofenac, ibuprofen, naproxen and piroxicam. Rev Esp Reumatol 1993;20(I):324.
- Brooks PM, Day RO. Nonsteroidal antiinfla mmatory drugs - differences and similarities. N Engl J Med 1991;324:1716-25.
- Guslandi M. Gastric toxicity of antiplatelet therapy with low-dose aspirin. Drugs 1997;53:1-5.
- Noble S, Balfour J. Meloxicam. Drugs 1996;51:424-30.
- Konstan MW, Byard PJ, Hoppel CL, et al. Effect of high dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995;332:848-54.
- Perneger TV, Whelton PК, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. N Engl J Med 1994;331:1675-712.
- Gillis JC, Brogden RN. Ketorolak. A reappraisal of its pharmacodinamic and pharmacokinetic properties and therapeutic use in pain management. Drugs 1997;53:139-88.
Supplementary files
